TESAMORELIN/ IPAMORELIN BLEND 12mg/6mg

TESAMORELIN/ IPAMORELIN BLEND 12mg/6mg

$110.00
Skip to product information
TESAMORELIN/ IPAMORELIN BLEND 12mg/6mg
  • TESAMORELIN/ IPAMORELIN BLEND 12mg/6mg
  • TESAMORELIN/ IPAMORELIN BLEND 12mg/6mg
TESAMORELIN/ IPAMORELIN BLEND 12mg/6mg

TESAMORELIN/ IPAMORELIN BLEND 12mg/6mg

$110.00
Shipping calculated at checkout.

TESAMORELIN / IPAMORELIN

Growth Hormone Signaling & Body Composition Research

What Is Tesamorelin / Ipamorelin?

Tesamorelin / Ipamorelin is a two-peptide research blend combining a growth hormone-releasing hormone analogue with a growth hormone secretagogue.

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone, a signal involved in directing the pituitary gland to produce and release growth hormone. Ipamorelin is studied for stimulating growth hormone release through a different signaling pathway.

This combination brings together two components relevant to investigating the regulation of growth hormone and its downstream biological activity.

Why Are Researchers Interested?

The growth hormone system plays a role in metabolism and tissue biology. Researchers investigate how changes in this system relate to IGF-1, fat distribution, and other measures of body composition.

Tesamorelin has been studied in the context of visceral adipose tissue—the fat located around internal organs. Ipamorelin research examines growth hormone release and the relationship between exposure to the peptide and the resulting hormone response.

These separate research backgrounds provide context for investigating the blend, while maintaining a distinction between individual-component findings and combination findings.

Key Areas of Research

Growth hormone release: Examining pituitary responses to different signaling inputs.
IGF-1 activity: Measuring downstream changes associated with growth hormone stimulation.
Visceral adipose tissue: Investigating internal abdominal fat in the specific settings studied for tesamorelin.
Body composition and metabolism: Exploring the relationship between hormone signaling, fat distribution, and tissue biology.

Research Context

Research involving prescription tesamorelin formulations applies to those specific formulations and study populations. It does not establish equivalent effects for a Tesamorelin / Ipamorelin research blend.

The blend’s component amounts and ratio are important characteristics for interpreting experimental results. Its total labeled peptide amount should be distinguished from the amount of each individual component.

Research Use Disclaimer

For laboratory and scientific research use only. Not intended for human or veterinary use, consumption, or administration. Not intended to diagnose, treat, cure, mitigate, or prevent any disease. Information on this page is provided for educational and research reference purposes and is not medical advice. Ethos Bioscience does not make medical claims regarding this product.
🧬 Mechanism

📖

Education

💉

Reconstitution
Details

Research Use Only

Ethos Bioscience compounds are supplied exclusively for lawful laboratory and scientific research. Product specifications, concentration, and labeling are provided on each individual product page.


Storage & Handling

Store according to the handling guidance provided with the product and protect from unnecessary heat, light, and moisture. Follow appropriate laboratory handling procedures at all times.


Important Notice

Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease or medical condition.
Shipping & Returns

Every Ethos Bioscience order is prepared with attention to accuracy, packaging integrity, and timely fulfillment. Orders are typically processed within 1–2 business days, with tracking provided once shipment is underway.


To protect product integrity, return requests are reviewed on a case-by-case basis. If your shipment arrives damaged, incorrect, or incomplete, please contact our team promptly so we can assess the issue and provide the appropriate resolution.

RESEARCH PROFILE / TESAMORELIN/ IPAMORELIN BLEND 12mg/6mg

THE SCIENCE, WITHOUT THE SCAVENGER HUNT.

Mechanism, evidence, limitations, and documentation - organized in one place.

RESEARCH CATEGORYResearch pathway profile
PRIMARY PATHWAYSCompound-specific signaling
MOLECULAR TYPEResearch material
RESEARCH STATUSInvestigational

01 / ORIENTATION

WHAT IS IT?

TESAMORELIN / IPAMORELIN

Growth Hormone Signaling & Body Composition Research

What Is Tesamorelin / Ipamorelin?

Tesamorelin / Ipamorelin is a two-peptide research blend combining a growth hormone-releasing hormone analogue with a growth hormone secretagogue.

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone, a signal involved in directing the pituitary gland to produce and release growth hormone. Ipamorelin is studied for stimulating growth hormone release through a different signaling pathway.

This combination brings together two components relevant to investigating the regulation of growth hormone and its downstream biological activity.

Why Are Researchers Interested?

The growth hormone system plays a role in metabolism and tissue biology. Researchers investigate how changes in this system relate to IGF-1, fat distribution, and other measures of body composition.

Tesamorelin has been studied in the context of visceral adipose tissue—the fat located around internal organs. Ipamorelin research examines growth hormone release and the relationship between exposure to the peptide and the resulting hormone response.

These separate research backgrounds provide context for investigating the blend, while maintaining a distinction between individual-component findings and combination findings.

Key Areas of Research

Growth hormone release: Examining pituitary responses to different signaling inputs.
IGF-1 activity: Measuring downstream changes associated with growth hormone stimulation.
Visceral adipose tissue: Investigating internal abdominal fat in the specific settings studied for tesamorelin.
Body composition and metabolism: Exploring the relationship between hormone signaling, fat distribution, and tissue biology.

Research Context

Research involving prescription tesamorelin formulations applies to those specific formulations and study populations. It does not establish equivalent effects for a Tesamorelin / Ipamorelin research blend.

The blend’s component amounts and ratio are important characteristics for interpreting experimental results. Its total labeled peptide amount should be distinguished from the amount of each individual component.

Research Use Disclaimer

For laboratory and scientific research use only. Not intended for human or veterinary use, consumption, or administration. Not intended to diagnose, treat, cure, mitigate, or prevent any disease. Information on this page is provided for educational and research reference purposes and is not medical advice. Ethos Bioscience does not make medical claims regarding this product.

02 / RESEARCH INTEREST

WHY RESEARCHERS ARE LOOKING

  • How compound-specific signaling is studied in controlled laboratory models
  • Which downstream cellular signals and measurable endpoints change
  • How dose, duration, model selection, and study design affect results
  • Where preclinical findings do—and do not—translate to human research

03 / MECHANISM

THE PATHWAY IS THE POINT.

This profile centers on compound-specific signaling. Researchers evaluate how activity within these pathways changes downstream signaling, biomarkers, and experimental endpoints. Results depend on the specific molecule, model, dose, duration, and study design.

04 / EVIDENCE AT A GLANCE

THE EVIDENCE, PROPERLY LABELED

RESEARCH CONTEXT

WHAT THE RESEARCH SHOWS

Published evidence for materials in this research category varies by molecule and may include mechanistic, in-vitro, animal, or human research. Product-specific conclusions require review of the named compound, study design, population, dose, duration, and measured endpoints.

WHAT IT DOES NOT ESTABLISH

Scientific literature does not independently establish the identity, purity, safety, or suitability of this supplied material. Mechanistic or preclinical findings should not be treated as proof of human outcomes, medical benefit, or product-specific quality.

05 / PUBLISHED RESEARCH

READ THE ACTUAL WORK.

Last reviewed: September 2026

Compound-specific references are being reviewed and will be added here as the research profile is expanded.

These publications concern named investigational molecules and pathway research. They provide scientific context; they do not independently validate this product or constitute medical guidance.

06 / QUALITY DOCUMENTATION

THE PAPER TRAIL BELONGS ON THE PAGE.

Product-specific documentation should be evaluated separately from published research.

BATCH
Available on product documentation
TEST DATE
See current report
DOCUMENT
Manufacturer Provided COA
COA LINK PENDING
RESEARCH USE NOTICE

For lawful laboratory and scientific research only. Not for human or veterinary use. Information is educational and is not medical advice.

Featured Collection

ETH - GI1 30MG

ETH - GI1 30MG

$150.00
MAP THE METABOLIC PATHWAY →
KLOW 80mg

KLOW 80mg

$110.00
MAP THE RECOVERY STACK →
NAD+ 500mg

NAD+ 500mg

$60.00
RECHARGE THE RESEARCH →
TESAMORELIN 10mg

TESAMORELIN 10mg

$70.00
TURN UP THE SIGNAL →
TB4 10mg

TB4 10mg

$65.00
TRACK TISSUE DYNAMICS →
AHK-CU 100mg

AHK-CU 100mg

$55.00
MAP THE METABOLIC PATHWAY →
BEAUTY BLEND 70mg

BEAUTY BLEND 70mg

$75.00
EXPLORE THE BEAUTY SIGNAL →
View all →